$JAZZ
Jazz Pharmaceuticals PLC

2019 Q4 Form 10-Q Financial Statement

#000123252419000060 Filed on November 05, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q4
Revenue $581.7M $537.7M $476.5M
YoY Change 22.1% 14.56% 9.18%
Cost Of Revenue $35.30M $31.40M $26.30M
YoY Change 34.22% 18.05% 4.37%
Gross Profit $541.2M $500.9M $441.0M
YoY Change 22.72% 14.2% 8.93%
Gross Profit Margin 93.03% 93.16% 92.56%
Selling, General & Admin $214.3M $178.7M $161.9M
YoY Change 32.37% 14.65% 13.22%
% of Gross Profit 39.6% 35.68% 36.71%
Research & Development $97.40M $79.86M $56.70M
YoY Change 71.78% 56.09% -23.38%
% of Gross Profit 18.0% 15.94% 12.86%
Depreciation & Amortization $177.9M $66.80M $50.30M
YoY Change 253.68% 31.24% -11.29%
% of Gross Profit 32.87% 13.34% 11.41%
Operating Expenses $485.2M $258.6M $265.1M
YoY Change 83.03% -7.85% -1.81%
Operating Profit $55.98M $133.1M $175.9M
YoY Change -68.18% -29.49% 30.44%
Interest Expense -$20.50M -$17.86M -$20.40M
YoY Change 0.49% -5.6% -10.13%
% of Operating Profit -36.62% -13.42% -11.6%
Other Income/Expense, Net
YoY Change
Pretax Income $40.80M $114.2M $164.6M
YoY Change -75.21% -32.46% 38.79%
Income Tax -$34.50M $10.90M $5.200M
% Of Pretax Income -84.56% 9.54% 3.16%
Net Earnings $73.99M $102.3M $159.5M
YoY Change -53.6% -31.5% -31.32%
Net Earnings / Revenue 12.72% 19.02% 33.47%
Basic Earnings Per Share $1.31 $1.80 $2.69
Diluted Earnings Per Share $1.29 $1.78 $2.64
COMMON SHARES
Basic Shares Outstanding 56.57M shares 56.67M shares 60.32M shares
Diluted Shares Outstanding 57.44M shares

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.077B $1.070B $824.6M
YoY Change 30.65% 0.58% 37.2%
Cash & Equivalents $637.3M $795.2M $309.6M
Short-Term Investments $744.2M $772.9M $515.0M
Other Short-Term Assets $78.90M $81.40M $67.57M
YoY Change 16.76% 49.88% -11.88%
Inventory $78.61M $71.11M $52.96M
Prepaid Expenses $39.43M $30.84M $25.02M
Receivables $356.0M $267.0M $263.8M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.630B $1.521B $1.234B
YoY Change 32.11% 3.84% 27.44%
LONG-TERM ASSETS
Property, Plant & Equipment $131.5M $129.5M $200.4M
YoY Change -34.36% -34.63% 17.8%
Goodwill $920.0M $906.7M $927.6M
YoY Change -0.82% -2.76% -2.1%
Intangibles $2.441B $2.593B $2.731B
YoY Change -10.63% -6.97% -8.32%
Long-Term Investments
YoY Change
Other Assets $47.91M $44.27M $42.70M
YoY Change 12.22% -20.94% 160.04%
Total Long-Term Assets $3.909B $4.007B $3.969B
YoY Change -1.53% -0.35% -4.47%
TOTAL ASSETS
Total Short-Term Assets $1.630B $1.521B $1.234B
Total Long-Term Assets $3.909B $4.007B $3.969B
Total Assets $5.539B $5.528B $5.203B
YoY Change 6.45% 0.77% 1.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.73M $70.10M $40.60M
YoY Change 12.63% 87.58% 66.62%
Accrued Expenses $269.7M $238.7M $264.9M
YoY Change 1.81% -7.27% 33.26%
Deferred Revenue $4.720M $4.720M $5.414M
YoY Change -12.82% -20.47% -37.18%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $33.39M $33.39M $33.39M
YoY Change 0.0% 0.0% -17.78%
Total Short-Term Liabilities $364.5M $390.4M $345.5M
YoY Change 5.5% 14.4% 17.53%
LONG-TERM LIABILITIES
Long-Term Debt $1.574B $1.571B $1.563B
YoY Change 0.69% 0.65% 1.47%
Other Long-Term Liabilities $109.4M $102.6M $218.9M
YoY Change -50.03% -50.83% 23.93%
Total Long-Term Liabilities $1.683B $1.673B $1.782B
YoY Change -5.54% -5.42% 3.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $364.5M $390.4M $345.5M
Total Long-Term Liabilities $1.683B $1.673B $1.782B
Total Liabilities $2.048B $2.064B $2.127B
YoY Change -3.74% -2.21% 5.79%
SHAREHOLDERS EQUITY
Retained Earnings $1.068B $1.104B $841.1M
YoY Change 26.96% -2.13% -8.38%
Common Stock $2.266B $2.209B $2.114B
YoY Change 7.21% 6.31% 9.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.111B $3.054B $2.757B
YoY Change
Total Liabilities & Shareholders Equity $5.539B $5.528B $5.203B
YoY Change 6.45% 0.77% 1.56%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q4
OPERATING ACTIVITIES
Net Income $73.99M $102.3M $159.5M
YoY Change -53.6% -31.5% -31.32%
Depreciation, Depletion And Amortization $177.9M $66.80M $50.30M
YoY Change 253.68% 31.24% -11.29%
Cash From Operating Activities $87.80M $337.5M $224.3M
YoY Change -60.86% 56.76% 9.63%
INVESTING ACTIVITIES
Capital Expenditures -$7.100M -$69.60M -$5.200M
YoY Change 36.54% 1684.62% -69.23%
Acquisitions
YoY Change
Other Investing Activities -$152.0M -$90.00M $38.90M
YoY Change -490.75% -50.41% -359.33%
Cash From Investing Activities -$159.1M -$159.6M $33.70M
YoY Change -572.11% -13.96% -205.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -87.70M -19.50M -446.4M
YoY Change -80.35% 39.29% 1016.0%
NET CHANGE
Cash From Operating Activities 87.80M 337.5M 224.3M
Cash From Investing Activities -159.1M -159.6M 33.70M
Cash From Financing Activities -87.70M -19.50M -446.4M
Net Change In Cash -159.0M 158.4M -188.4M
YoY Change -15.61% 902.53% -241.97%
FREE CASH FLOW
Cash From Operating Activities $87.80M $337.5M $224.3M
Capital Expenditures -$7.100M -$69.60M -$5.200M
Free Cash Flow $94.90M $407.1M $229.5M
YoY Change -58.65% 85.72% 3.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
Jazz Pharmaceuticals plc
CY2018Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
107000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
758000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
-80000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
-769000 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Central Index Key
EntityCentralIndexKey
0001232524
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2593030000 USD
CY2018Q4 jazz Capital Redemption Reserve
CapitalRedemptionReserve
472000 USD
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33500
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
L2
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1032470
dei Entity Address Address Line1
EntityAddressAddressLine1
Fifth Floor, Waterloo Exchange,
dei Entity Address Address Line2
EntityAddressAddressLine2
Waterloo Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin 4
dei Entity Address Country
EntityAddressCountry
IE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
D04 E5W7
dei Country Region
CountryRegion
353
dei City Area Code
CityAreaCode
1
dei Local Phone Number
LocalPhoneNumber
634-7800
dei Security12b Title
Security12bTitle
Ordinary shares, nominal value $0.0001 per share
dei Trading Symbol
TradingSymbol
JAZZ
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56572721 shares
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
795175000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309622000 USD
CY2019Q3 us-gaap Investments
Investments
275000000 USD
CY2018Q4 us-gaap Investments
Investments
515000000 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
267031000 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
263838000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
71108000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
52956000 USD
CY2019Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
30841000 USD
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25017000 USD
CY2019Q3 us-gaap Other Assets Current
OtherAssetsCurrent
81401000 USD
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
67572000 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
1520556000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
1234005000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
129472000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200358000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
141878000 USD
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2018Q4 us-gaap Goodwill
Goodwill
927630000 USD
CY2019Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
183944000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
188777000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2731334000 USD
CY2019Q3 us-gaap Goodwill
Goodwill
906725000 USD
CY2018Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
57879000 USD
CY2019Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
7971000 USD
CY2018Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
9589000 USD
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
44274000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42696000 USD
CY2019Q3 us-gaap Assets
Assets
5527850000 USD
CY2018Q4 us-gaap Assets
Assets
5203491000 USD
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
70104000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
40602000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
238740000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
264887000 USD
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
33387000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
33387000 USD
CY2019Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
43488000 USD
CY2018Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1197000 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4720000 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5414000 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
390439000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
345487000 USD
CY2019Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
6041000 USD
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9581000 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1570781000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1563025000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
153434000 USD
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2019Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
250167000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
309097000 USD
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
102583000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
218879000 USD
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
6000 USD
CY2019Q3 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2018Q4 jazz Nonvoting Euro Deferred Shares
NonvotingEuroDeferredShares
55000 USD
CY2019Q3 jazz Capital Redemption Reserve
CapitalRedemptionReserve
472000 USD
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2209156000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
471129000 USD
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-197791000 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1104158000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2113630000 USD
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-259442000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
841050000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
3054405000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
2757422000 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5527850000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5203491000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
537702000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
469373000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1580021000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1414465000 USD
CY2019Q3 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
31400000 USD
CY2018Q3 jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
26574000 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
92582000 USD
jazz Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment
95207000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
178706000 USD
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
155873000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
522667000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
521665000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
79855000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51160000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
202344000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
169959000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
62863000 USD
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
46989000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
181324000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
154955000 USD
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2018Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
42896000 USD
CY2019Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
51775000 USD
CY2018Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
109975000 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
404599000 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
280596000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1108892000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-54017000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-59171000 USD
us-gaap Costs And Expenses
CostsAndExpenses
984682000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
133103000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
429783000 USD
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-17861000 USD
CY2018Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-18920000 USD
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1033000 USD
CY2018Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-756000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3577000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5181000 USD
CY2019Q3 jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
CY2018Q3 jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
-1425000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
114209000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
169101000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
413535000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
364006000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10903000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19348000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-38631000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75018000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1030000 USD
CY2018Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-437000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2791000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1360000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
102276000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
149316000 USD
us-gaap Net Income Loss
NetIncomeLoss
449375000 USD
us-gaap Net Income Loss
NetIncomeLoss
287628000 USD
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.80
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.78
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.78
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.68
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56674000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60476000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56860000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60196000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57438000 shares
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
102276000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
149316000 USD
us-gaap Net Income Loss
NetIncomeLoss
449375000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61493000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61857000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57647000 shares
us-gaap Net Income Loss
NetIncomeLoss
287628000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-48448000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11984000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-56271000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-43945000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-558000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
746000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-5380000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
5304000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-49006000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-11238000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-61651000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-38641000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53270000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
138078000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
387724000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
248987000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
2757422000 USD
CY2018Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
4848000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3057000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13810000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27861000 USD
CY2019Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
111249000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22883000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
85201000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
2730447000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7033000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
6032000 USD
CY2019Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1003000 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28658000 USD
CY2019Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
59869000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10238000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
261898000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2983434000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9968000 USD
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1087000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28817000 USD
CY2019Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
19997000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-49006000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
102276000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
3054405000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
2713097000 USD
CY2017Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-298000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10588000 USD
CY2018Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
14594000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24276000 USD
CY2018Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
34546000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
42057000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
45991000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
2786571000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
51023000 USD
CY2018Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5447000 USD
CY2018Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1429000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26294000 USD
CY2018Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
21015000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-69460000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
92321000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
2869752000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16998000 USD
CY2018Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1169000 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25112000 USD
CY2018Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
21454000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-11238000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
149316000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
3027317000 USD
us-gaap Net Income Loss
NetIncomeLoss
449375000 USD
us-gaap Net Income Loss
NetIncomeLoss
287628000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
181324000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
154955000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
84626000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
75718000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
42896000 USD
us-gaap Depreciation
Depreciation
10885000 USD
us-gaap Depreciation
Depreciation
11363000 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
109975000 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-8000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-652000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-167935000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-44658000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
3847000 USD
jazz Provision For Losses On Accounts Receivable And Inventory
ProvisionForLossesOnAccountsReceivableAndInventory
4734000 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
0 USD
jazz Gain Losson Extinguishmentand Modificationof Debt
GainLossonExtinguishmentandModificationofDebt
-1425000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
34415000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
32669000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
4437000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6970000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4307000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
55518000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23028000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7583000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
22858000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6989000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2251000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
244000 USD
jazz Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-10919000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
29104000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10116000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-37369000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
65074000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
42813000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-13999000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4234000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5623000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3634000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
7244000 USD
jazz Increase Decrease In Operating Lease Liabilities Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent
-3137000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
688603000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
580808000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
820000000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
565000000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
48092000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
32998000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
15221000 USD
jazz Payment To Acquire Assets Net Of Cash Acquired
PaymentToAcquireAssetsNetOfCashAcquired
55074000 USD
jazz Payment To Acquire Assets Net Of Cash Acquired
PaymentToAcquireAssetsNetOfCashAcquired
0 USD
jazz Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination
PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination
61700000 USD
jazz Paymentsto Acquire In Process Researchand Development Other Than Through Business Combination
PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
80500000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
111100000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
585975000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
921250000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3753000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-434479000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
26090000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
84056000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15900000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17192000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
25040000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
17370000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
191115000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
77015000 USD
jazz Payments For Proceeds From Tenant Allowance Financing Activities
PaymentsForProceedsFromTenantAllowanceFinancingActivities
0 USD
jazz Payments For Proceeds From Tenant Allowance Financing Activities
PaymentsForProceedsFromTenantAllowanceFinancingActivities
-1253000 USD
us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
0 USD
us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
6406000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-205965000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-32674000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-838000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-672000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
485553000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
112983000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
309622000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
386035000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
795175000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
499018000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.</span></div>
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200358000 USD
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104961000 USD
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
149442000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
264887000 USD
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
273052000 USD
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
153158000 USD
CY2018Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
309097000 USD
CY2019Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
310586000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
218879000 USD
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
105264000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
841050000 USD
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
845898000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="line-height:120%;padding-top:18px;text-indent:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Risk</span></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash, cash equivalents, investments and derivative contracts. Our investment policy permits investments in U.S. federal government and federal agency securities, corporate bonds or commercial paper issued by U.S. corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, and tax-exempt obligations of U.S. states, agencies and municipalities and places restrictions on credit ratings, maturities, and concentration by type and issuer. We are exposed to credit risk in the event of a default by the financial institutions holding our cash, cash equivalents and investments to the extent recorded on the balance sheet.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We manage our foreign currency transaction risk and interest rate risk within specified guidelines through the use of derivatives. All of our derivative instruments are utilized for risk management purposes, and we do not use derivatives for speculative trading purposes. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had foreign exchange forward contracts with notional amounts totaling </span><span style="font-family:inherit;font-size:10pt;"><span>$226.1 million</span></span><span style="font-family:inherit;font-size:10pt;">. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, the outstanding foreign exchange forward contracts had a net liability fair value of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.7 million</span></span><span style="font-family:inherit;font-size:10pt;">. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, we had interest rate swap contracts with notional amounts totaling </span><span style="font-family:inherit;font-size:10pt;"><span>$300.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. These outstanding interest rate swap contracts had a net liability fair value of </span><span style="font-family:inherit;font-size:10pt;"><span>$2.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">. The counterparties to these contracts are large multinational commercial banks, and we believe the risk of nonperformance is not significant.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are also subject to credit risk from our accounts receivable related to our product sales. We monitor our exposure within accounts receivable and record a reserve against uncollectible accounts receivable as necessary. We extend credit to pharmaceutical wholesale distributors and specialty pharmaceutical distribution companies, primarily in the U.S., and to other international distributors and hospitals. Customer creditworthiness is monitored and collateral is not required. We monitor deteriorating economic conditions in certain European countries which may result in variability of the timing of cash receipts and an increase in the average length of time that it takes to collect accounts receivable outstanding. Historically, we have not experienced significant credit losses on our accounts receivable and as of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, allowances on receivables were not material. As of </span><span style="font-family:inherit;font-size:10pt;">September 30, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">two</span><span style="font-family:inherit;font-size:10pt;"> customers accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>88%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, Express Scripts Specialty Distribution Services, Inc. and its affiliates, or Express Scripts, the central pharmacy for Xyrem, which accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>83%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, and McKesson Corporation and affiliates, or McKesson, which accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>5%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable. As of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">two</span><span style="font-family:inherit;font-size:10pt;"> customers accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>89%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, Express Scripts, which accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>74%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable, and McKesson, which accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>15%</span></span><span style="font-family:inherit;font-size:10pt;"> of gross accounts receivable. </span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We depend on single source suppliers for most of our products, product candidates and their APIs. With respect to Xyrem, the API is manufactured for us by a single source supplier and the finished product is manufactured both by us in our facility in Athlone, Ireland and by our U.S.-based Xyrem supplier.</span></div>
CY2019Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1070175000 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2019Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2019Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1070175000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
795175000 USD
CY2019Q3 us-gaap Investments
Investments
275000000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
824622000 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
824622000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309622000 USD
CY2018Q4 us-gaap Investments
Investments
515000000 USD
CY2019Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
4500000 USD
CY2019Q3 us-gaap Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement
DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
1009000 USD
CY2019Q3 us-gaap Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement
DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
3758000 USD
CY2018Q4 us-gaap Derivative Asset Fair Value Gross Asset Including Not Subject To Master Netting Arrangement
DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement
5264000 USD
CY2018Q4 us-gaap Derivative Liability Fair Value Gross Liability Including Not Subject To Master Netting Arrangement
DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement
1460000 USD
CY2019Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11653000 USD
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
10895000 USD
CY2019Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
33935000 USD
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
20743000 USD
CY2019Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
25520000 USD
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
21318000 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
71108000 USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
52956000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
927630000 USD
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
52855000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
49608000 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
129472000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-20905000 USD
CY2019Q3 us-gaap Goodwill
Goodwill
906725000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3262595000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
804612000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2457983000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3236894000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
647565000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2589329000 USD
CY2019Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3397642000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
804612000 USD
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2593030000 USD
CY2018Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3378899000 USD
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
647565000 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2731334000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
173131000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
246957000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
201390000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
157785000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
157785000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1520935000 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2457983000 USD
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
182327000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
249966000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
200358000 USD
CY2019Q3 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
86191000 USD
CY2018Q4 jazz Accrued Rebates And Other Sales Deductions
AccruedRebatesAndOtherSalesDeductions
86495000 USD
CY2019Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
64595000 USD
CY2018Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
58543000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11713000 USD
CY2019Q3 jazz Accrued Inventory Related Liabilities
AccruedInventoryRelatedLiabilities
10433000 USD
CY2018Q4 jazz Accrued Inventory Related Liabilities
AccruedInventoryRelatedLiabilities
8753000 USD
CY2019Q3 jazz Accrued Clinical Trial Liability
AccruedClinicalTrialLiability
7973000 USD
CY2018Q4 jazz Accrued Clinical Trial Liability
AccruedClinicalTrialLiability
5904000 USD
CY2019Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
6705000 USD
CY2018Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
6780000 USD
CY2019Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
6074000 USD
CY2018Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2679000 USD
CY2019Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4213000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2333000 USD
CY2019Q3 jazz Accrued Construction In Progress
AccruedConstructionInProgress
3070000 USD
CY2018Q4 jazz Accrued Construction In Progress
AccruedConstructionInProgress
1065000 USD
CY2019Q3 jazz Sales Return Reserve
SalesReturnReserve
2872000 USD
CY2018Q4 jazz Sales Return Reserve
SalesReturnReserve
2510000 USD
CY2019Q3 jazz Accrued Interest
AccruedInterest
2539000 USD
CY2018Q4 jazz Accrued Interest
AccruedInterest
7407000 USD
CY2019Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2427000 USD
CY2018Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1460000 USD
CY2019Q3 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
0 USD
CY2018Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
58154000 USD
CY2019Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
29935000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
22804000 USD
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
238740000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
264887000 USD
CY2019Q3 us-gaap Long Term Debt
LongTermDebt
1604168000 USD
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
1596412000 USD
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
33387000 USD
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
33387000 USD
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1570781000 USD
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1563025000 USD
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
8347000 USD
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
33387000 USD
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
608387000 USD
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
33387000 USD
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
517494000 USD
CY2019Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
575000000 USD
CY2019Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1776002000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
5746000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
17672000 USD
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
396000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
1616000 USD
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
0 USD
us-gaap Variable Lease Cost
VariableLeaseCost
4000 USD
CY2019Q3 us-gaap Sublease Income
SubleaseIncome
158000 USD
us-gaap Sublease Income
SubleaseIncome
478000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
5984000 USD
us-gaap Lease Cost
LeaseCost
18814000 USD
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
141878000 USD
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11713000 USD
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
153434000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
165147000 USD
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.053
us-gaap Operating Lease Payments
OperatingLeasePayments
11758000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
153048000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4531000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
20954000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
20843000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
20889000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
21260000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
128294000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
216771000 USD
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
51624000 USD
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
165147000 USD
CY2019Q3 us-gaap Unrecorded Unconditional Purchase Obligation Balance On First Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
79800000 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-60632000 USD
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
1019000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-61651000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
102276000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
149316000 USD
us-gaap Net Income Loss
NetIncomeLoss
449375000 USD
us-gaap Net Income Loss
NetIncomeLoss
287628000 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56674000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60476000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56860000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60196000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
764000 shares
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1381000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
787000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1297000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57438000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61857000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57647000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61493000 shares
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.80
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.78
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.78
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.68
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
537702000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
469373000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1580021000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1414465000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
537702000 USD
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
469373000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1580021000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1414465000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
14995000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4234000 USD
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
10761000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28785000 USD
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25103000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
84626000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
75718000 USD
CY2019Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4106000 USD
CY2018Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3552000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
12246000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
12066000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
24679000 USD
CY2018Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
21551000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
72380000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
63652000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-38600000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75000000.0 USD
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.095
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.093
CY2018Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.114
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.206
jazz Discrete Income Tax Expense Benefit
DiscreteIncomeTaxExpenseBenefit
-112300000 USD

Files In Submission

Name View Source Status
0001232524-19-000060-index-headers.html Edgar Link pending
0001232524-19-000060-index.html Edgar Link pending
0001232524-19-000060.txt Edgar Link pending
0001232524-19-000060-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
jazz-20190930.xsd Edgar Link pending
jazz-20190930_cal.xml Edgar Link unprocessable
jazz-20190930_def.xml Edgar Link unprocessable
jazz-20190930_lab.xml Edgar Link unprocessable
jazz-20190930_pre.xml Edgar Link unprocessable
jazz2019q3doc.htm Edgar Link pending
jazz2019q3doc_htm.xml Edgar Link completed
jazzq32019ex101.htm Edgar Link pending
jazzq32019ex102.htm Edgar Link pending
jazzq32019ex103.htm Edgar Link pending
jazzq32019ex104.htm Edgar Link pending
jazzq32019ex105.htm Edgar Link pending
jazzq32019ex106.htm Edgar Link pending
jazzq32019ex311.htm Edgar Link pending
jazzq32019ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending